Generic placeholder image

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Research Article

Benzophenone Esters and Sulfonates: Synthesis and their Potential as Antiinflammatory Agents

Author(s): Arshia, Almas Jabeen, Aisha Faheem, Khalid M. Khan*, Shazia Shah and Shahnaz Perveen

Volume 15, Issue 2, 2019

Page: [162 - 174] Pages: 13

DOI: 10.2174/1573406414666180806114825

Price: $65

Abstract

Background: Inflammation is a biological rejoinder of vascular tissues against destructive agents e.g. irritants, damaged cell or pathogens. During inflammation, respiratory burst occurs by activated phagocytes which help to destroy invading pathogens. Phagocytic cells such as neutrophils and macrophages are one of the major sources of reactive oxygen species (ROS) and nitric oxide (NO). Normally, the redox environment is maintained by various antioxidant defense systems, however, these reactive oxygen species may be destructive and can lead to various pathological conditions.

Methods: Benzophenone esters and sulfonates (1-18) were synthesized through one pot synthesis by reacting 4-hydroxy benzophenone either different benzoyl chloride or sulfonyl chloride. These synthetic compounds were evaluated for their in vitro immunosuppressive potential on two parameters of innate immune response including inhibition of intracellular reactive oxygen species (ROS) and nitric oxide (NO). ROS were induced in polymorphonuclear leukocytes (PMNs) isolated from human whole blood by serum opsonized zymosan stimulation, whereas NO were produced in J774.2 cells by lipopolysachharides (LPS) stimulation. Moreover, cytotoxicity of compounds was also determined using NIH-3T3 fibroblast cells (ATCC, Manassas, USA) was evaluated by using the standard MTT colorimetric assay.

Results: All compounds inhibited the production of ROS at various extent among which compounds 2, 5, 6, 8, 10, 13 and 16 were found to be the potent inhibitors of ROS with IC50 values ranging between (1.0 - 2.2 µg/mL) as compared to ibuprofen (IC50 = 2.5 ± 0.6 µg/mL) as the standard drug. Compounds 2, 7, 11, 13, 14 and 18 showed good inhibition of NO production with % inhibition values ranging between (63.6% - 76.7%) at concentration of 25 µg/mL as compared to NG-monomethyl-Larginine (L-NMMA 65.6 ± 1.1 µg/mL) as the standard. All other derivatives showed moderate to low level of inhibition on both tested parameters. Cytotoxicity activity also showed nontoxicity of synthetic compounds. Structures of all the synthetic compounds were confirmed through 1H-NMR, 13C-NMR, EI-MS and HREI-MS spectroscopic techniques.

Conclusion: Compounds 2 and 13 were found to be good dual antiinflammatory (ROS and NO) agent. However, compounds 5, 6, 8, 10 and 16 were found to be selectively active for ROS inhibitory studies. Compounds 7, 11, 14 and 18 were discriminatory active at NO inhibition assay. These initial findings of antiinflammatory activity concluded that these compounds might have the potential to develop a novel non-steroidal antiinflammatory drugs (NSAIDs), non-acidic antiinflammatory agent. Most active compounds 2, 5-8, 10, 13, 14 and 16 showed nontoxicity of synthetic compounds.

Keywords: Benzophenone, ester, sulfonates, immunosuppressive, Reactive Oxygen Species (ROS), Nitric Oxide (NO).

Graphical Abstract
[1]
Boscá, L.; Zeini, M.; Través, P.G.; Hortelano, S. Nitric oxide and cell viability in inflammatory cells: A role for NO in macrophage function and fate. Toxicology, 2005, 208, 249-258.
[2]
Ferrero-Miliani, L.; Nielsen, O.H.; Andersen, P.S.; Girardin, S.E. Chronic inflammation: importance of NOD2 and NALP3 in interleukin‐1β generation. Exp. Immuno., 2007, 147, 227-235.
[3]
Palladino, M.A.; Bahjat, F.R.; Theodorakis, E.A.; Moldawer, L.L. AntiTNF-α therapies: The next generation. Nat. Rev. Drug Discov., 2003, 2, 736-746.
[4]
Leval, X.d.; Ulémont, F.J.; Delarge, J.; Pirotte, B.; Dogné, J-M. New trends in dual 5-LOX/COX inhibition. Curr. Med. Chem., 2002, 9, 941.
[5]
Geronikaki, A.A.; Lagunin, A.A.; Hadjipavlou-Litina, D.I.; Eleftheriou, P.T.; Filimonov, D.A.; Poroikov, V.V.; Alam, I.; Saxena, A.K. Computer-aided discovery of antiinflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. J. Med. Chem., 2008, 51, 1601.
[6]
Oldenburg, B.; Van, H. Kats-Renaud.; Koningsberger, J.C.; Van, B.H.G.P.; Van, A.B.S. Chemiluminescence in inflammatory bowel disease patients: a parameter of inflammatory activity. Clin. Chim. Acta, 2001, 310, 151-156.
[7]
Kunsch, C.; Medford, R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res., 1999, 85, 753-766.
[8]
Gupta, A.K.; Chitme, H.; Dass, S.K.; Misra, N. Antioxidant activity of Chamomile recutita capitula methanolic extracts against CCl4-induced liver injury in rats. J. Pharm. Toxicol., 2006, 1, 101-107.
[9]
Dahlgren, C.; Briheim, G. Comparison between the luminol‐dependent chemiluminescence of polymorphonuclear leukocytes and of the myeloperoxidase‐hooh system: influence of ph, cations and protein. Photochem. Photobiol., 1985, 41, 605-610.
[10]
Connell, D. Volatile flavouring constituents of the pineapple. I. Some esters, alcohols, and carbonyl compounds. Aust. J. Chem., 1964, 17, 130-140.
[11]
Kalua, C.; Allen, M.; Bedgood, D.; Bishop, A.; Prenzler, P.; Robards, K. A Critical Review, Olive oil volatile compounds, flavour development and quality: A critical review. Food Chem., 2007, 100, 273-286.
[12]
Devitt, L.C.; Sawbridge, T.; Holton, T.A.; Mitchelson, K.; Dietzgen, R.G. Discovery of genes associated with fruit ripening in Carica papaya using expressed sequence tags. Plant Sci., 2006, 170, 356-363.
[13]
Xi, P.; Xia, H.; Zhao, F.; Chen, B. Syntheses and luminescence properties of EU (III) complexes with benzoic acid carboxymethyl ester derivatives. Mater. Lett., 2015, 160, 463-467.
[14]
Zygmunt, M.; Chłoń-Rzepa, G.; Sapa, J.; Pawłowski, M. Analgesic activity of new 8-methoxy-1, 3-dimethyl-2,6-dioxo-purin-7-yl derivatives with carboxylic, ester or amide moieties. Pharmacol. Rep., 2015, 67, 9-16.
[15]
Xiao, H.; Li, P.; Hu, D.; Song, B.A. Synthesis and AntiTMV activity of novel β-amino acid ester derivatives containing quinazoline and benzothiazole moieties. Bioorg. Med. Chem. Lett., 2014, 24, 3452-3454.
[16]
Akinboye, E.S.; Bamji, Z.D.; Kwabi-Addo, B.; Ejeh, D.; Copeland, R.L.; Denmeade, S.R.; Bakare, O. Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines. Bioorg. Med. Chem., 2015, 23, 5839-5845.
[17]
Machado, K.C.; Oliveira, G.L.S.; Machado, K.C.; Islam, M.T.; Junior, A.L.G.; De Sousa, D.P.; Freitas, R.M. Anticonvulsant and behavioral effects observed in mice following treatment with an ester derivative of ferulic acid: Isopentyl ferulate. Chem. Biol. Interact., 2015, 242, 273-279.
[18]
Sivajothi, V.; Dakappa, S.S. in vitro and in silico antidiabetic activity of pyran ester derivative isolated from Tragia cannabina. Asian Pac. J. Trop. Biomed., 2014, 4, S455-S459.
[19]
El-Faham, A.; Al Marhoon, Z.; Abdel-Megeed, A.; Khattab, S.N.; Bekhit, A.A.; Albericio, F. α-Ketoamino acid ester derivatives as promising MAO inhibitors. Bioorg. Med. Chem. Lett., 2015, 25, 70-74.
[20]
Daniel, K.B.; Jourden, J.L.M.; Negoescu, K.E.; Cohen, S.M. Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide. J. Biol. Inorg. Chem., 2011, 16, 313-323.
[21]
El-Gamal, M.I.; Oh, C.H. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives. Eur. J. Med. Chem., 2014, 84, 68-76.
[22]
Biswas, R.; Mukherjee, P.K.; Dalai, M.K.; Mandal, P.K.; Nag, M. Tyrosinase inhibitory potential of purpurin in Rubia cordifolia—A bioactivity guided approach. Ind. Crops Prod., 2015, 74, 319-326.
[23]
Zhang, S.; Lu, X.; Wang, N.; Buck, R.C. Biotransformation potential of 6: 2 fluorotelomer sulfonate (6: 2 FTSA) in aerobic and anaerobic sediment. Chemosphere, 2016, 154, 224-230.
[24]
Chang, Y.H.; Lee, Y.D.; Karlsson, O.J.; Sundberg, D.C. Surfactant characteristics of random block polyelectrolyte polyester emulsifier (SMTAPE) in aqueous solution and on polystyrene latex particles. Polymer , 2000, 41, 6741-6747.
[25]
Shen, Y.; Xi, J.; Qiu, X.; Zhu, W. A new proton conducting membrane based on copolymer of methyl methacrylate and 2-acrylamido-2-methyl-1-propanesulfonic acid for direct methanol fuel cells. Electrochim. Acta, 2007, 52, 6956-6961.
[26]
Rattanakawin, C.; Hogg, R. Viscosity behavior of polymeric flocculant solutions. Miner. Eng., 2007, 20, 1033-1038.
[27]
Sun, L.; Wu, J.; Luo, M.; Wang, X.; Pan, M.; Gou, Z.; Sun, D. Diversity oriented design of various benzophenone derivatives and their in vitro antifungal and antibacterial activities. Molecules, 2011, 16, 9739-9754.
[28]
Belluti, F.; De Simone, A.; Tarozzi, A.; Bartolini, M.; Djemil, A.; Bisi, A.; Bottegoni, G. Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer’s disease. Eur. J. Med. Chem., 2014, 78, 157-166.
[29]
Abdel-Mageed, W.M.; Bayoumi, S.A.; Chen, C.; Vavricka, C.J.; Li, L.; Malik, A.; Gao, G.F. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum antiviral activity. Bioorg. Med. Chem., 2014, 22, 2236-2243.
[30]
Maciel-Rezende, C.M. Almeida, L.de.; Costa, É.D.M.; Pires, F.R.; Alves, K.F.; Junior, C.V.; dos Santos, M.H. Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones. Bioorg. Med. Chem., 2013, 21, 3114-3119.
[31]
Arshia, A.; Khan, A.; Khan, K.M.; Saad, S.M.; Siddiqui, N.I.; Javaid, S.; Choudhary, M.I. Synthesis and urease inhibitory activities of benzophenone semicarbazones/thiosemicarbazones. Med. Chem. Res., 2016, 25, 2666-2679.
[32]
Venu, T.D.; Shashikanth, S.; Khanum, S.A.; Naveen, S.; Firdouse, A.; Sridhar, M.A.; Prasad, J.S. Synthesis and crystallographic analysis of benzophenone derivatives—The potential antiinflammatory agents. Bioorg. Med. Chem., 2007, 15, 3505-3514.
[33]
Khanum, S.A.; Bushra, A.; Girish, B.V.; Khanum, N.F. 2-Benzoyl-4-chlorophenyl benzoate. Int. J. Biomed. Sci., 2010, 6, 60-65.
[34]
Bandgar, B.P.; Chavan, H.V.; Adsul, L.K.; Thakare, V.N.; Shringare, S.N.; Shaikh, R.; Gacche, R.N. Design, synthesis, characterization and biological evaluation of novel pyrazole integrated benzophenones. Bioorg. Med. Chem. Lett., 2013, 23, 912-916.
[35]
Palomer, A.; Pascual, J.; Cabre, M.; Borras, L.; Gonzalez, G.; Aparicim, M.; Mauleon, D. Structure-based design of cyclooxygenase-2 selectivity into ketoprofen. Bioorg. Med. Chem. Lett., 2002, 12, 533.
[36]
Buttgereit, F.; Burmester, G.R.; Simon, L.S. Gastrointestinal toxic side effects of nonsteroidal antiinflammatory drugs and cyclooxygenase-2–specific inhibitors. Am. J. Med., 2001, 110, 13-19.
[37]
Ekström, P.; Carling, L.; Wetterhus, S.; Wingren, P.E.; Anker-Hansen, O.; Lundegårdh, G.; Unge, P. Scan, prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal antiinflammatory drug therapy: a nordic multicentre study. J. Gastroenterol., 1996, 31, 753-758.
[38]
Khan, K.M.; Ambreen, N.; Mughal, U.R.; Jalil, S.; Perveen, S.; Choudhary, M.I. 3-Formylchromones: Potential antiinflammatory agents. Eur. J. Med. Chem., 2010, 45, 4058-4064.
[39]
Khan, K.M. Zia-Ullah, Lodhi, M.A.; Jalil, S.; Choudhary, M.I.; Atta-ur-Rahman. Synthesis and antiinflammatory activity of some selected aminothiophene analogs. J. Enzyme Inhib. Med. Chem., 2006, 21, 139-143.
[40]
Kaboudin, B. Methanesulfonic acid/phosphorus oxychloride (MAPO) as a new efficient reagent in the Fries rearrangement. Tetrahedron, 1999, 55, 12865-12872.
[41]
Murata, M.; Oda, T.; Sogabe, Y.; Tone, H.; Namikoshi, T.; Watanabe, S. Synthesis and antiinflammatory activity of some selected aminothiophene analogs. Chem. Lett., 2011, 40, 962-963.
[42]
Koivunen, J.T.; Nissinen, L.; Juhakoski, A.; Pihlavisto, M.; Marjamäki, A.; Huuskonen, J.; Pentikäinen, O.T. Blockage of collagen binding to integrin α2β1: structure–activity relationship of protein–protein interaction inhibitors. MedChemComm, 2011, 2, 764-770.
[43]
Mesaik, M.A.; Jabeen, A.; Halim, S.A.; Begum, A.; Khalid, A.S.; Asif, M.; Choudhary, M.I. In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa. Chem. Biol. Drug Des., 2012, 79, 290-299.
[44]
El Ashry, E.S.H.; El Tamany, E.S.H.; Abd El Fattah, M.E.D.; Aly, M.R.; Boraei, A.T.; Mesaik, M.A.; Soomro, S. Immunomodulatory properties of S- and N-alkylated 5-(1H-indol-2-yl)-1,3,4-oxadiazole-2(3H)-thione. J. Enzyme Inhib. Med. Chem., 2013, 28, 105-112.
[45]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65, 55-63.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy